INTENSITY THERAPEUTICS, INC. (INTS) Debt Components
- 2023-06-30: Convertible Notes Payable, CurrentUSD (m); Convertible Notes PayableUSD (m); Debt Instrument, Convertible, Number of Equity Instrumentspure 6 month · 139971600.00%; Debt Instrument, Unamortized DiscountUSD (m).
- 2023-06-30: Convertible Notes Payable, CurrentUSD (m); Convertible Notes PayableUSD (m); Debt Instrument, Convertible, Number of Equity Instrumentspure (m); Debt Instrument, Unamortized DiscountUSD $117.70K.
- 2022-12-31: Convertible Notes Payable, CurrentUSD $4.35M; Convertible Notes PayableUSD $4.35M; Debt Instrument, Convertible, Number of Equity Instrumentspure (m); Debt Instrument, Unamortized DiscountUSD $117.70K.
INTENSITY THERAPEUTICS, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Convertible Notes Payable, Current USD | Convertible Notes Payable USD | Debt Instrument, Convertible, Number of Equity Instruments pure | Debt Instrument, Unamortized Discount USD |
|---|---|---|---|---|
| 2023-06-30 | (m) | (m) | 6 month · 139971600.00% | (m) |
| 2023-06-30 | (m) | (m) | (m) | $117.70K |
| 2022-12-31 | $4.35M | $4.35M | (m) | $117.70K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |